Sumo-dependent substrate targeting of the SUMO protease Ulp1 by Elmore, Zachary C et al.
W&M ScholarWorks 
Arts & Sciences Articles Arts and Sciences 
2011 
Sumo-dependent substrate targeting of the SUMO protease Ulp1 
Zachary C. Elmore 
College of William and Mary 
Megan Donaher 
Brooke C. Matson 
College of William and Mary 
Helen Murphy 
College of William and Mary, hamurphy@wm.edu 
Jason W. Westerbeck 
College of William and Mary 
See next page for additional authors 
Follow this and additional works at: https://scholarworks.wm.edu/aspubs 
Recommended Citation 
Elmore, Zachary C.; Donaher, Megan; Matson, Brooke C.; Murphy, Helen; Westerbeck, Jason W.; and 
Kerscher, Oliver, Sumo-dependent substrate targeting of the SUMO protease Ulp1 (2011). 
10.1186/1741-7007-9-74 
This Article is brought to you for free and open access by the Arts and Sciences at W&M ScholarWorks. It has been 
accepted for inclusion in Arts & Sciences Articles by an authorized administrator of W&M ScholarWorks. For more 
information, please contact scholarworks@wm.edu. 
Authors 
Zachary C. Elmore, Megan Donaher, Brooke C. Matson, Helen Murphy, Jason W. Westerbeck, and Oliver 
Kerscher 
This article is available at W&M ScholarWorks: https://scholarworks.wm.edu/aspubs/15 
Sumo-dependent substrate targeting of the
SUMO protease Ulp1
Elmore et al.
Elmore et al. BMC Biology 2011, 9:74
http://www.biomedcentral.com/1741-7007/9/74 (28 October 2011)
RESEARCH ARTICLE Open Access
Sumo-dependent substrate targeting of the
SUMO protease Ulp1
Zachary C Elmore, Megan Donaher, Brooke C Matson, Helen Murphy, Jason W Westerbeck and Oliver Kerscher*
Abstract
Background: In the yeast Saccharomyces cerevisiae, the essential small ubiquitin-like modifier (SUMO) protease Ulp1
is responsible for both removing SUMO/Smt3 from specific target proteins and for processing precursor SUMO into
its conjugation-competent form. Ulp1 localizes predominantly to nuclear pore complexes but has also been shown
to deconjugate sumoylated septins at the bud-neck of dividing cells. How Ulp1 is directed to bud-neck localized
septins and other cytoplasmic deconjugation targets is not well understood.
Results: Using a structure/function approach, we set out to elucidate features of Ulp1 that are required for
substrate targeting. To aid our studies, we took advantage of a catalytically inactive mutant of Ulp1 that is greatly
enriched at the septin ring of dividing yeast cells. We found that the localization of Ulp1 to the septins requires
both SUMO and specific structural features of Ulp1’s catalytic domain. Our analysis identified a 218-amino acid,
substrate-trapping mutant of the catalytic domain of Ulp1, Ulp1(3)(C580S), that is necessary and sufficient for septin
localization. We also used the targeting and SUMO-binding properties of Ulp1(3)(C580S) to purify Smt3-modified
proteins from cell extracts.
Conclusions: Our study provides novel insights into how the Ulp1 SUMO protease is actively targeted to its
substrates in vivo and in vitro. Furthermore, we found that a substrate-trapping Ulp1(3)(C580S) interacts robustly with
human SUMO1, SUMO2 and SUMO2 chains, making it a potentially useful tool for the analysis and purification of
SUMO-modified proteins.
Background
Cell division is a fundamental feature of all life and
involves the controlled duplication and faithful segrega-
tion of an organism’s genetic material from one cell to
the next. In eukaryotes, each cell division cycle is there-
fore executed as a tightly regulated, stepwise program
that relies on intact chromosomes. In humans, the con-
sequences of faulty chromosome segregation and the
inability to repair DNA damage have been implicated in
cancer, aging and congenital birth defects.
Ubiquitin and small ubiquitin-like modifier (SUMO),
two small proteins that can become attached to other
cellular proteins in a reversible manner [1], control
important aspects of the cell division program. Ubiquitin
is best known for its role in the targeted, proteasome-
mediated destruction of proteins, including key cell-
cycle regulators, but also holds nonproteolytic functions
[2]. Sumoylation, on the other hand, does not directly
target proteins for degradation. Rather, modification of
proteins with SUMO has been shown to modulate var-
ious cellular processes, including cell-cycle regulation,
transcriptional activation, nucleocytoplasmic transport,
DNA replication and repair, chromosome dynamics,
apoptosis, ribosome biogenesis, and the formation of
nuclear bodies [3]. Additionally, an unexpected role of
SUMO in protein ubiquitination has been uncovered.
Briefly, degradation of several nuclear proteins, includ-
ing some that are involved in DNA repair and transcrip-
tional regulation, are preceded by modification with
SUMO. These sumoylated proteins are recognized by
SUMO-targeted ubiquitin ligases (STUbLs), which med-
iate their ubiquitination [4].
SUMO proteins are highly conserved from yeast to
humans. Yeast cells express one SUMO protein (Smt3),
and vertebrates express three isoforms (SUMO1,
SUMO2 and SUMO3) [5]. SUMO2, SUMO3 and yeast
Smt3 can form SUMO chains. SUMO1, on the other
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hand, lacks the internal lysine required for polymeriza-
tion and may function as a chain terminator for
SUMO2 and SUMO3 chains [6]. All SUMO variants are
conjugated to lysine residues of specific proteins, but
only a fraction of these target proteins are modified
with SUMO at any given time [7,8]. In metazoans, the
dysregulation of sumoylation adversely affects develop-
mental processes and has been implicated in the pro-
gression of neurodegeneration, cancer and infectious
diseases [9,10]. More than 1, 000 sumoylated proteins
have been identified in yeast and humans, but only in a
few cases has the role of sumoylation been studied in
detail [11].
In the budding yeast Saccharomyces cerevisiae, the
ligation of SUMO to specific substrate proteins requires
an E1 heterodimer (Aos1 and Uba2) that activates
SUMO, as well as E2 (Ubc9) and E3 (Siz1, Siz2, and
Mms21) enzymes that aid in the conjugation and liga-
tion of SUMO to proper target proteins [1]. Two yeast
SUMO proteases, Ulp1 and Ulp2, contain a conserved
cysteine protease domain that can remove the SUMO
moiety from modified proteins. Recent evidence suggests
that Ulp2, and its mammalian orthologs Susp1/SENP6
and SENP7, play a role in the removal of SUMO and
SUMO chains from nuclear proteins [12-16]. Ulp1, on
the other hand, has two contrasting cellular functions.
Ulp1 facilitates sumoylation by processing precursor
SUMO into its conjugation competent form. Conversely,
Ulp1 also facilitates desumoylation by removing SUMO
from nuclear and cytosolic proteins after conjugation
[17]. Therefore, impairment of Ulp1 results in the accu-
mulation of SUMO conjugates and the inability to carry
out de novo sumoylation. The resulting lack of mature
SUMO has been shown to adversely affect cellular DNA
repair processes, the processing and export of the 60S
preribosomal particle, nucleus-cytoplasm trafficking and
cell viability [18-21].
The substrate specificity of SUMO proteases is at least
in part regulated through their localization [22]. For
example, certain yeast (Ulp2) and vertebrate (SENP6
and SENP7) SUMO proteases localize within the
nucleus. In contrast, both yeast (Ulp1) and vertebrate
(SENP1 and SENP2) SUMO proteases reside at the
nuclear envelope (NE) through their interactions with
the nuclear pore complex (NPC) [23-26]. Distinct
domains have been identified that are required for Ulp1
NPC localization (amino acid residues 1 to 403) and
SUMO processing (amino acid residues 404 to 620)
[25-28]. The Ulp1 localization domain promotes interac-
tion with karyopherins, which are soluble proteins that
mediate transport across the NE and help localize Ulp1
to the nucleoplasmic side of the NPC. The Ulp1 locali-
zation domain can be subdivided into region 1 (Kap121-
binding domain) and region 2 (Kap60- and Kap95-
binding domain). Juxtaposed to the NPC localization
domain of Ulp1 is a coiled-coil (cc) domain with a puta-
tive nuclear export signal and region 3, the catalytically
active, conserved ubiquitin-like protease domain (UD) of
Ulp1 [25-27]. Only regions 1 and 2 are involved in Ulp1
localization to the NPC, and the karyopherins seem to
play a redundant role. NPC association of Ulp1 requires
several proteins, including the nucleoporins Nup60 and
Nup84, the silencing protein Esc1 and the myosin-like
proteins Mlp1/2 [18,19,28]. Together these proteins may
provide a scaffold for the functional regulation and sub-
strate access of Ulp1 at the NPC.
The identification of NPC localization domains in
Ulp1 has done little to aid our understanding of how
SUMO proteases are targeted to their respective sub-
strates [26]. One possibility is that SUMO proteases
may contain structural features which allow for nonco-
valent interactions with SUMO and SUMO-modified
proteins as they enter the nucleus. Indeed, conserved
SUMO-interacting motifs (SIMs) have been predicted to
be localized in the yeast SUMO protease Ulp2, as well
as in mammalian SENP1, SENP2, SENP6 and SENP7
[14,22,29,30]. Even though SIMs have not been identi-
fied in Ulp1, the crystal structure of the catalytic domain
(region 3) bound to Smt3 reveals that both proteins
interact through multiple residues that are distributed
across a SUMO-binding surface (SBS) on the SUMO
protease [31]. Only the carboxy terminus of bound
Smt3 is inserted into a hydrophobic tunnel that leads
toward Ulp1’s active site. SUMO processing and decon-
jugation require an active site cysteine residue that
resides at the end of this tunnel (see Additional files 1
and 2). It has been suggested that this configuration
may allow for the accommodation of many different
sumoylated proteins as well as SUMO precursors [31].
Ulp1 and several other SUMO proteases play impor-
tant roles in mitosis [17,32]. In budding yeast, loss of
Ulp1-mediated desumoylation leads to cell-cycle pro-
gression defects and cell death [17]. This observation
suggests that Ulp1 plays a key role in the sumoylation
dynamics of important cell-cycle regulatory proteins.
Though these cell-cycle-specific targets have eluded
identification, several nuclear and cytosolic proteins
involved in DNA replication and mitosis have been
identified as Ulp1 desumoylation substrates [33-35].
How the NPC-localized Ulp1 is targeted to these mitotic
substrates, especially those that are localized in the cyto-
sol, is not entirely clear. In budding yeast, the NE does
not break down during mitosis, and access to cytosolic
desumoylation targets is therefore not automatic. It has
been reported that during mitosis, Kap121 blocks Ulp1’s
access to its NPC-binding site and thus promotes an
interaction of Ulp1 with septins [27]. A deletion mutant
of Ulp1 lacking region 2 (Δ2), the Kap60- and Kap95-
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binding domain, has previously been shown to localize
to septins in a Kap121-dependent manner [27]. Cur-
iously, it has recently been demonstrated that region 2
also plays a role in nucleolar accumulation of Ulp1 after
ethanol-induced stress [36].
One set of cytosolic substrates of the Ulp1 SUMO
protease are the septins [27,35]. The septins comprise
an evolutionarily conserved class of GTPases that are
implicated in bud-site selection, bud emergence and
growth, microtubule capture and spindle positioning
[37]. Members of the septin family in yeast include
Cdc3, Cdc10, Cdc11, Cdc12 and Shs1/Sep7. These pro-
teins are unique because they can form filaments that
assemble into a ring structure and mark the site of new
bud formation during cell division. At the end of mito-
sis, this ring separates and resembles a double-collar
residing at the junction between the mother and daugh-
ter cells.
The septins Cdc3, Cdc11 and Shs1 are subject to
sumoylation. Sumoylation of the septins occurs very
briefly from the onset of anaphase to cytokinesis, with
SUMO being attached only to the mother side of the
double-septin ring collar [27,38,39]. Cell-cycle (G2/M)
arrest with nocodazole, a microtubule depolymerizing
drug, greatly increases SUMO conjugation to septins
[38]. Septin sumoylation in budding yeast is mediated
by the SUMO E3 ligase Siz1 [40,41]. During most of the
cell cycle, Siz1 resides in the nucleus. However, at the
M phase, Siz1 exits the nucleus to sumoylate septin pro-
teins and possibly other cytosolic substrates [42]. Dele-
tion of SIZ1 from cells abolishes septin sumoylation
while causing only mild growth and cell-cycle progres-
sion defects. At the end of mitosis, the septins are desu-
moylated by Ulp1, even though Ulp1 remains visibly
enriched at the NPC [27,35,38].
In the current study, we focused on the SUMO pro-
tease Ulp1. As detailed above, Ulp1 resides at the inner
face of the NPC. This enrichment at the NPC depends
on direct interactions with karyopherins and two
domains in the amino terminus of Ulp1. In theory, this
localization is well-suited to give Ulp1 access to some
nuclear substrates and those in transit across the NE.
However, both nuclear and cytosolic desumoylation tar-
gets of Ulp1 have been identified, posing an interesting
question. How is Ulp1 directed to its cytosolic desumoy-
lation targets? To answer these questions, we sought to
identify features of Ulp1 required for substrate targeting
in vivo and in vitro. Herein we describe our finding that
the carboxy terminus of Ulp1 affects the targeting and
retention of this SUMO protease to sumoylated target
proteins, including septins, at the bud-neck of dividing
cells. Specifically, we show that the interaction with
SUMO comprises an important aspect of the subcellular
targeting of Ulp1 to these substrates. Our findings are
confirmed by biochemical analyses that focus on the
SUMO-binding properties of Ulp1(3)C580S, a novel trun-
cation mutant that interacts avidly with SUMO and
sumoylated proteins in vivo and in vitro. Significantly,
the results of this study add important new details to
our understanding of how Ulp1 interacts dynamically
with its substrates and also provides potentially useful
new directions for the study of Ulp1-interacting
proteins.
Results
Ulp1 localization to the nuclear envelope and the septin
ring
As part of a larger study to identify how Ulp1 is tar-
geted to its mitotic desumoylation substrates, we ana-
lyzed the localization of GFP-tagged versions of both
the full-length wild-type (WT) Ulp1 and a catalytically
inactive mutant of Ulp1 (Ulp1C580S) in G2/M-arrested
yeast cells (see Methods and Additional file 3). The
C580S mutation replaces the catalytic cysteine with a
serine residue, rendering the Ulp1 SUMO protease cata-
lytically inactive [17]. Both fusion proteins were
expressed under the control of the Ulp1 promoter on
low-copy plasmids, and images were collected using a
fluorescence microscope. Consistent with its localization
to NPCs, WT Ulp1 stained only the NE of arrested
yeast cells (Figure 1A, left). Unexpectedly, however, full-
length Ulp1C580S was enriched at both the bud-neck and
the NE of G2/M-arrested cells (Figure 1A, right). This
bud-neck localization of Ulp1C580S is reminiscent of the
localization of the septin ring. Several sumoylated sep-
tins have been shown to be Ulp1 substrates, and we
show in this study that the septin Cdc3 is highly sumoy-
lated during G2/M arrest (Figure 1B). Furthermore, a
catalytically inactive Ulp1 mutant colocalizes with the
septin Cdc11 in G2/M-arrested (noc) cells (Figure 1C).
Therefore, Ulp1C580S resides at the bud-neck localized
septin ring.
Our data suggest that introducing the C580S mutation
into the catalytic domain of Ulp1 somehow alters the
subcellular distribution of this SUMO protease, causing
it to localize with a bud-neck-associated substrate, possi-
bly a sumoylated septin protein. Localization changes
have also been reported for catalytically inactive, sub-
strate-trapping mutants of phosphatases that form stable
complexes with their substrates in vivo [43].
SUMO conjugation is required for Ulp1 localization to the
septin ring
We tested whether the C580S mutation that visually
increased the ability of Ulp1 to associate with the septin
ring in vivo was, in fact, SUMO-dependent. For this
purpose, the Ulp1C580S construct was expressed in two
Smt3 mutants (smt3-331 and smt3-R11, 15, 19) or two
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SUMO pathway mutants (ubc9-1, siz1Δ siz2Δ)
[13,39,41,44-46]. Logarithmically growing cells of each
mutant were arrested in G2/M, and images were col-
lected to assess the septin ring localization of Ulp1C580S
in comparison to an SMT3 WT strain. In our analyses,
we found that in the absence of both SUMO chains (in
the R11, 15, 19 mutants) and a mutant SUMO protein
(in the smt3-331 mutant), the localization of Ulp1C580S
to the septin ring was reduced (22% in smt3-331 and
36% in smt3-R11, 15, 19) in frequency and intensity but
not abolished (Figure 2). We obtained different results
in the ubc9-1 strain, a mutant of the SUMO E2-conju-
gating enzyme which impairs SUMO conjugation, and
in the siz1Δ siz2Δ strain, a SUMO E3 ligase double-
mutant that lacks sumoylation of septins and many
other proteins [40,41,44]. Consistent with a role for
Smt3 in the localization of Ulp1C580S, we were unable to
detect septin ring localization of Ulp1C580S in ubc9-1
Figure 1 Localization of Ulp1 and the catalytically inactive Ulp1(C580S) in dividing yeast cells. (A) Yeast cells (MHY500) were transformed
either with a low-copy plasmid expressing GFP fusions of Ulp1 or with the catalytically inactive Ulp1(C580S) mutant. Representative images
indicating the localization of GFP-tagged Ulp1 and Ulp1(C580S) after nocodazole-induced G2/M arrest are shown (YOK 1611 and YOK 1474). Note
that only the Ulp1(C580S) mutant can be seen at the bud-neck of arrested cells. The arrowhead indicates the position of the bud-neck. (B)
Confirmation of sumoylation of Cdc3 was achieved. Whole-cell extracts (WCE) from yeast cells expressing the YFP-tagged septin Cdc3 (YOK 1398)
were treated with nocodazole (noc) or grown logarithmically (log) prior to preparation of WCEs. Extracted proteins were then separated on SDS-
PAGE gels and probed with the JL-8 antibody (see Methods) to detect Cdc3-YFP and more slowly migrating sumoylated Cdc3-YFP adducts. The
identity of sumoylated Cdc3-YFP bands was confirmed by comparing gel shift assays with untagged and FLAG-tagged Smt3 (data not shown).
(C) Colocalization of Cdc3 and Ulp1 is shown. A strain coexpressing full-length Ulp1(C580S)-GFP (green) and Cdc3-CFP (red) (strain YOK 2204) was
arrested in G2/M and then observed under a fluorescence microscope with the appropriate filter sets (left panel). Arrowheads indicate septin-
localized, pseudocolored Ulp1-GFP (green), Cdc3-CFP (red) and the merged image (overlay). Also shown for comparison (right panel) is the
colocalization of the Ulp1(3)(C580S)-GFP truncation and Cdc3-CFP (strain YOK 2205). Ulp1(3)(C580S)-GFP is described in Figure 4.
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and siz1Δ siz2Δ strains. However, Ulp1C580S was
retained at the NE (Figure 2A). As an additional control,
the septin ring localization of GFP-tagged Smt3 was
undetectable in both ubc9-1 and siz1Δ siz2Δ strains
(Figure 2B).
Smt3 conjugation is required for Ulp1 localization to
the septin ring. Therefore, Ulp1 is targeted to the septin
ring of dividing cells in a SUMO-dependent fashion.
Our data also suggest that the formation of SUMO
chains on substrates may enhance this targeting of Ulp1.
Distinct and separate Ulp1 domains are required for
localization to the septin ring
Our finding that a single point mutation in Ulp1,
C580S, dramatically enhanced the localization of full-
length Ulp1 to the septin ring in a SUMO-dependent
fashion warranted a more detailed analysis of the target-
ing domains in Ulp1. Therefore, we generated a collec-
tion of GFP-tagged Ulp1 truncations and domains that
were expressed under control of the Ulp1 promoter.
We reasoned that the truncations and domains of Ulp1
that retained substrate targeting information would also
localize to the septin ring in G2/M-arrested cells. In all,
we assessed the localization of ten GFP-tagged con-
structs in comparison to full-length WT Ulp1 and full-
length Ulp1C580S (C580S). Our choice of individual con-
structs was guided by previous findings that Ulp1 con-
sists of functionally separate domains. These domains
include a Kap121-binding domain with a role in septin
localization (region 1), a Kap95- and Kap60-binding
domain with a role in NPC anchoring (region 2), a cc
domain harboring a nuclear export signal (CC) and the
catalytic UD (region 3) [25-27]. Representative images
of these domains and their subcellular localization are
shown in Figures 3A and 3B. As previously reported,
we found that the Ulp1 protein lacking region 2 (Δ2)
localized to the septin ring in the majority of large-
budded, arrested cells [27]. Therefore, region 2 of Ulp1
normally antagonizes localization and/or retention at
the septin ring. This result is complemented by our
novel finding that the full-length Ulp1C580S localized to
the septin ring in 33% of all arrested, large-budded cells
(Figures 1A and 3A).
Next we investigated other residues of Ulp1 that could
affect the septin ring localization of the Ulp1C580S
mutant, possibly by interfering with its targeting to
sumoylated substrates. Aspartate 451 (D451) in Ulp1 is
required to form an essential salt bridge with arginine
64 of Smt3 [31,47]. Therefore, we introduced a D451N
mutation into Ulp1C580S and found that it abolished the
Figure 2 Small ubiquitin-like modifier (SUMO) is required for the localization of Ulp1(C580S) to the septin ring. (A) The indicated mutants
smt3-331, ubc9-1, smt3-R11, 15, 19, siz1Δ siz2Δ (YOK 1995, YOK 2065, YOK 1910 and YOK 2067) and a WT control strain (WT) were transformed
with a plasmid expressing GFP-tagged Ulp1(C580S). Representative images indicating the localization of GFP-tagged Ulp1(C580S) after G2/M arrest
are shown. The septin ring localization of Ulp1(C580S) is indicated where present (arrowheads). Note that Ulp1(C580S) failed to localize to the septin
ring in SUMO-conjugating and ligating enzyme mutants (ubc9-1 and siz1Δ siz2Δ, respectively). (B) Septin ring localization of Smt3-GFP is absent
in ubc9-1 and siz1Δ siz2Δ strains. Localization of Smt3-GFP was visualized in G2/M-arrested WT, ubc9-1 and siz1Δ siz2Δ strains (YOK 1857, YOK 2144
and YOK 2143) using fluorescence microscopy. Arrowheads indicate the position of the septin ring.
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Figure 3 Distinct and separate Ulp1 domains are required for localization to the septin ring. (A) and (B) Left: A schematic of Ulp1
deletion and truncation mutants used in this study is shown. The length of each construct (amino acid scale 1 to 621), the individual domains
of Ulp1 and pertinent amino acid changes are shown. WT: full-length Ulp1; region 1: Ulp1(1 to 150); region 2: Ulp1(151 to 340); region 3: Ulp1
(341 to 621); Δ2: Ulp1 lacking region 2; C580S: catalytically inactivating mutation; D451N: deleted salt bridge with small ubiquitin-like modifier
(SUMO) (YOK 1611, YOK 1474, YOK 1490, YOK 1861, YOK 1479, YOK 2016, YOK 1839, YOK 1907, YOK 1903, YOK 2203, YOK 1828 and YOK 2157).
Colored letters N, S and D summarize the observed nuclear, septin and diffuse localization of the indicated constructs, respectively. SBS
corresponds to a shallow SUMO-binding surface on Ulp1 [31,57,58]. Right: Representative images of G2/M-arrested cells expressing the GFP-
tagged Ulp1 constructs shown on the left. The arrowheads indicate the fraction of cells (%) with N, S or D localization and the presence and
position of septin ring-localized Ulp1 constructs. (C) Quantification of distinct subcellular localization of wild-type and mutant Ulp1 region 3
constructs. Large-budded G2/M-arrested cells were imaged to assess diffuse, nuclear or septin ring localization (n > 100).
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accumulation of the full-length Ulp1 double-mutant
(D451N and C580S) at the septin ring (Figure 3A). This
finding underscores the importance of Smt3 in targeting
full-length Ulp1 to the septin ring shown in Figure 2.
Additionally, it may indicate that D451 is required for
targeting of sumoylated proteins and the C580S muta-
tion is required for retention of Ulp1 at the septin ring.
Most intriguingly, we found that a truncation consist-
ing only of region 3 with the C580S mutation (Ulp1(3)
(C580S)) displayed robust septin ring localization in 59%
of cells (Figures 1C, right panel, and Figure 3B). In stark
contrast, regions 1 and 2 and WT region 3, lacking the
C580S mutation, failed to localize to the septin ring
(Figures 3A and 3B). However, in strains with diffuse
Ulp1 truncations, the septin ring stays intact. Therefore,
necessary and sufficient SUMO-dependent targeting
information is contained in region 3 of Ulp1, but not in
regions 1 and 2. The latter conclusion is confirmed by
two-hybrid assays with Smt3.
The previously published cocrystal structure of Ulp1
with Smt3 (MMDB database 13315) reveals that amino
acids 418 to 447 of region 3 make extensive contact
with Smt3 and constitute an exposed SBS [31] (see also
Additional files 1 and 2). The SBS is situated next to,
but does not include, the critical D451 residue that con-
tacts Smt3 [31,47]. Additionally, deletion of this SBS in
region 3 of Ulp1 abolishes the complementation of a
ulp1Δ deletion mutant [26]. In an attempt to identify
critical residues in the evolutionary conserved SBS
domain, we used psi-blast to compare the protein
sequence of the yeast Ulp1 catalytic domain with all
nonredundant protein sequences in the National Center
for Biotechnology Information database for seven itera-
tions and limited the output to the top 250 matches.
Our results contained 81 different species. Among these
species, 61% of the sequences were identified as verified
or predicted sentrin/SUMO protease/Ulp1 genes, 24%
were identified as unnamed protein products or
hypothetical genes and 15% were classified as “other”
(crystal structures, unanalyzed sequences and so on).
The alignment of these sequences allowed us to identify
areas of strong conservation (see Additional file 1).
Using this approach, we identified several highly con-
served residues in the SBS. However, these amino acids
did not contact Smt3 in the published cocrystal struc-
ture and likely play structural roles in Ulp1 folding [31].
We investigated the effect of deleting the entire SBS
domain on the localization of Ulp1(3)(C580S). A Ulp1(3)
(C580S)SBSΔ construct did not localize to the septin ring
in the majority of cells (96%). These results match those
obtained by Li and Hochstrasser [26] using a WT Ulp1
(3)ΔSBS construct (C173). We confirmed that SBSΔ and
other Ulp1(3) constructs are expressed as soluble pro-
teins, suggesting that they are not grossly misfolded. We
also cloned and expressed the SBS domain as a fusion
with GFP (SBS-GFP). This construct was distributed dif-
fusely throughout the cell and failed to localize to the
septin ring (Figure 3, middle). These data suggest that
the SBS domain of region 3 may be required for the
initial interaction with sumoylated substrates, but addi-
tional features of Ulp1 are required for targeting (D451)
and retention (C580S) of this SUMO protease at the
septin ring.
Next we directed our attention to the temperature-
sensitive ulp1ts-333 allele. This mutant allele causes
cells to arrest in mitosis and accumulates unprocessed
SUMO precursor and sumoylated proteins [17]. Our
ulp1ts construct of region 3, Ulp1(3)ts, contains three
mutations (I435V, N450S and I504T), and introduction
of C580S into Ulp1(3)ts showed a greatly reduced inci-
dence and intensity of septin ring localization (compare
panels in Figures 3B and 3C). We noted that the
(N450S) mutation in the ts construct was located next
to the salt bridge-forming residue D451 described above
and that both residues were highly conserved in the
consensus sequence of Ulp1-like molecules (Additional
file 1). This suggests that residues altered in ulp1ts-333,
specifically N450, may contribute to Smt3 interaction
and possibly substrate targeting. It is possible that
N450S perturbs the salt-bridge interaction formed
between D451 of Ulp1 and R64 of Smt3, thus reducing
the interaction with Smt3 and contributing to the tem-
perature-sensitive phenotype. In support of this hypoth-
esis, correction of the N450S mutation in Ulp1(3)ts
(S450N) partially rescued the slow growth defect of a
ulp1Δ strain at 30°C and 37°C (data not shown). The
effect of the ulp1ts mutation on Ulp1’s ability to interact
with Smt3 is explored in more detail below.
We tested which domains of Ulp1 are required for
targeting and retention at the septin ring in vivo. Using
our region 1 and region 2 GFP-tagged constructs (see
Figure 3A), we show that septin-targeting information is
not contained in the domains that are known to interact
with karyopherins. The Δ2 construct recapitulates the
previous finding that Kap121-binding to region 1 regu-
lates access of Ulp1 to the septin ring. The full-length
Ulp1C580S mutant reveals that a single substrate-trapping
mutation in Ulp1 suffices to enrich Ulp1 at the septin
ring. To show that an Smt3 interaction is required for
the septin localization of Ulp1C580S, we created the dou-
ble-mutant (D451N and C580S). The D451N mutation
is known to destroy an essential salt bridge formed
between Smt3 and Ulp1. Next, using the Ulp1(3)C580S
construct, we show that the septin-targeting information
is limited to region 3 of Ulp1 (Figure 3B). Further trun-
cating Ulp1(3)C580S revealed that a previously identified
SBS domain in Ulp1(3)C580S is also involved in septin
targeting and retention. To test whether mutations
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found in region 3 of the ulp1ts mutant play a role in
septin localization, we introduced three additional muta-
tions, I435V, N450S and I504T, into Ulp1(3)C580S. This
Ulp1(3)ts C580S construct showed a reduced ability to
enrich at the septin ring (Figure 3C), suggesting that its
ability to interact with sumoylated septins may be
reduced but not abolished.
Kap121-independent SUMO-targeting information resides
in the catalytic domain of Ulp1
In the preceding sections, we described our identifica-
tion of necessary and sufficient substrate-targeting infor-
mation in the catalytic domain (region 3) of Ulp1.
However, region 3 of Ulp1 may not be the only domain
involved in targeting to the septin ring. Region 1 of
Ulp1, the Kap121-binding domain, has previously been
implicated in septin targeting. Specifically, it has been
reported that Kap121 is required for targeting Ulp1 to
the septin ring during mitosis [27]. Therefore, we
decided to assess the role of Kap121 in the substrate-
targeting of Ulp1(3)(C580S). Specifically, we used a
kap121ts mutant [48] to assess the septin ring-targeting
of WT Ulp1, full-length Ulp1C580S and Ulp1(3)(C580S). In
our analysis, we found that full-length Ulp1C580S
required Kap121 function for targeting to the septin
ring. At the permissive temperature (30°C), Ulp1C580S
demarcated the NE and septin ring of G2/M-arrested
cells. After a shift to the nonpermissive temperature,
however, Ulp1C580S could no longer be detected at the
septin ring (Figure 4, middle). Surprisingly, the Ulp1(3)
(C580S) truncation was localized to the septin ring at the
permissive and nonpermissive temperatures in a
kap121ts strain. As shown herein, Ulp1(3)(C580S) resided
both inside the nucleus and at the septin ring at 30°C
and 37°C (Figure 4, right).
Our data suggest that Ulp1 contains both Kap121-
dependent and Kap121-independent septin ring-target-
ing information. The only requirement to detect full-
length Ulp1 at the septin ring is the C580S mutation
and functional Kap121 (Figures 1, 2 and 4). In contrast
Ulp1(3)(C580S), which lacks all domains required for NPC
interaction through Kap121, Kap60 and Kap95, localizes
to the septin ring and inside the nucleus. This finding
provides strong evidence that Kap121-independent sep-
tin ring-targeting information resides in the catalytic
domain (region 3) of Ulp1.
Multiple features in the catalytic domain of Ulp1 affect
SUMO interactions
Our finding that a single amino acid change in the cataly-
tic domain of Ulp1 results in greatly enhanced, SUMO-
dependent localization to the septin ring also prompted
us to investigate the two-hybrid interactions of Ulp1 with
budding yeast SUMO (Smt3-BD; Smt3 fused to the Gal4
DNA-binding domain). Full-length WT Ulp1, the full-
length catalytically inactive Ulp1C580S mutant, the Ulp1
Kap121-interacting domain (region 1), the Ulp1 Kap60/
Kap95-interacting domain (region 2) and the catalytic
domain (region 3) failed to interact with Smt3-BD (data
not shown). However, the catalytically inactive Ulp1(3)
(C580S) truncation interacted reproducibly and above
background with Smt3 (see Figure 5, C580S).
Ulp1(3)(C580S) appears to interact only weakly with our
Smt3 two-hybrid bait construct, as indicated by fewer
Figure 4 Kap121-independent small ubiquitin-like modifier (SUMO)-targeting information resides in region 3 of Ulp1. kap121ts cells
were transformed with plasmids expressing GFP-tagged wild-type (WT) Ulp1, Ulp1(C580S) and Ulp1(3)(C580S) under the control of the Ulp1
promoter (YOK 1487, YOK 1488 and YOK 1944). Shown are representative images indicating the localization of GFP-tagged Ulp1 constructs in
large-budded cells at 30°C and 37°C, the nonpermissive temperature for kap121-ts. Arrowheads indicate the position of septin ring-localized Ulp1
constructs.
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colonies on the reporter media (Figure 5, Ade). However,
such an interpretation assumes an equally available pool
of both bait and prey. One possible explanation for this
result is that the Ulp1(3)(C580S) two-hybrid prey construct
interacts with a number of available substrates in the cell
(for example, free Smt3 and other sumoylated proteins),
and, as a result, this sequestration is no longer available
to the Smt3 two-hybrid bait construct, thus creating the
appearance of a weak interaction. We reasoned that
introduction of the ulp1ts mutations could weaken the
potential substrate-trapping phenotype of Ulp1(3)(C580S),
making more of the pool available to engage the Smt3
bait construct. Consistent with this model, when we
introduced the ulp1ts mutations into the substrate-trap-
ping Ulp1(3)(C580S) prey construct, we observed a more
robust two-hybrid interaction with the Smt3 bait (Figure
5, compare C580S and ts(C580S). It must also be noted,
however, that currently we cannot fully explain the varia-
tions in our in vivo and in vitro assays used to assess abil-
ity of Ulp1(3)(C580S) to interact with Smt3.
Next we focused on the D451N mutant of Ulp1 that
prevents the interaction of Ulp1 with SUMO [31,47]. As
shown above, D451N, when introduced into Ulp1(C580S),
prevents localization of this construct to the septin ring
(Figure 3A, C580S/D451N). Correspondingly, we found
that introduction of the D451N mutation into Ulp1(3)
(C580S) completely abolished the two-hybrid interaction
with Smt3 (Figure 5, compare C580S, D451N/C580S
and D451N). These observations provide evidence that
the targeting of Ulp1 to sumoylated substrates is a clo-
sely balanced act involving both Smt3 targeting and
retention.
Ulp1(3)(C580S) truncation binds SUMO and SUMO-modified
proteins
We hypothesized that if Ulp1(3)(C580S) were to interact
avidly with Smt3, this mutated moiety of Ulp1 could
efficiently interact with SUMO adducts in vitro. There-
fore, to test the direct interaction of Ulp1(3)(C580S) with
SUMO, we fused this domain to the carboxy terminus
of maltose-binding protein (MBP) and expressed the
recombinant fusion protein in bacteria. Subsequently,
the MBP-Ulp1(3)(C580S) fusion protein was purified from
bacterial extracts and bound to amylose resin (see
Methods). As a control to assess the ability of MBP-
Ulp1(3)(C580S) to interact with sumoylated proteins, we
also purified a second MBP-fused Ulp1(3)(C580S) con-
struct lacking the SBS domain (3(C580S)ΔSBS).
First we determined the ability of MBP-Ulp1(3)(C580S) to
affinity-purify sumoylated proteins from crude yeast cell
extracts. ulp1ts-333 cells expressing FLAG-tagged SMT3
were grown to log phase prior to preparation of yeast cell
extracts (see Methods). These extracts were then incu-
bated with resin-bound MBP-Ulp1(3)(C580S), MBP-Ulp1(3)
(C580S)-ΔSBS or unbound amylose resin. After washing,
bound yeast proteins were eluted, separated on SDS-
PAGE gels and examined by Western blot analysis with an
anti-FLAG antibody. Flag-SMT3-modified proteins pre-
sent in the whole-cell extracts (WCEs) (Figure 6, lane 2)
could clearly be detected bound to MBP-Ulp1(3)(C580S)
(lane 5) but not to the MBP-Ulp1(3)(C580S)-ΔSBS control
protein (lane 4). We identified both unconjugated Flag-
Smt3 proteins as well as several higher-molecular-weight
adducts. These data suggest that Ulp1(3)(C580S) can effi-
ciently bind and enrich sumoylated proteins from crude
yeast cell extracts. To demonstrate the versatility of Ulp1
(3)(C580S)-aided Smt3 purification, we also purified mono-
meric and conjugated GFP-Smt3 from yeast cells (Figure
6B). Additionally, we probed the extracts and eluted pro-
teins shown in Figure 6B with an anti-Cdc11 antibody,
which revealed the specific copurification of Cdc11 with
immobilized Ulp1(3)(C580S) (Figure 6C).
In the reciprocal experiment, we tested whether a
GFP-tagged Ulp1(3)(C580S) construct expressed in yeast
Figure 5 Distinct and separate features of Ulp1 are required for interaction with SUMO. Two-hybrid analysis of various Ulp1(3) truncation
mutants (C580S: catalytically inactive; D451N: deleted salt bridge with small ubiquitin-like modifier (SUMO); ts: mutations including S450N in
ulp1ts-333) with SUMO/Smt3-BD. The presence of both Smt3 (pOBD2/TRP1) and Ulp1 constructs (pOAD/LEU2) was confirmed by growth on
growth media lacking tryptophan and leucine (-T-L). The interaction between Ulp1 constructs and Smt3 is shown as triplicate patches of cells on
media lacking adenine (-A). See Figure 3A for a graphic representation of individual constructs.
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Figure 6 The Ulp1(3)(C580S) truncation binds SUMO and SUMO-modified proteins. (A) and (B) Immobilized Ulp1(3)(C580S) was analyzed for
its ability to affinity-purify Smt3 from yeast whole-cell extracts (WCEs). WCEs containing FLAG-tagged Smt3 (YOK 428) (left) or GFP-Smt3 (YOK
1857) (right) (input) were prepared under nondenaturing conditions and incubated with immobilized maltose-binding protein (MBP)-Ulp1(3)
(C580S) (3(C580S)), MBP-Ulp1(3)(C580S) lacking the small ubiquitin-like modifier (SUMO)-binding surface (3(C580S)ΔSBS) or unbound resin (amylose). After
washing and elution, bound Smt3 and Smt3 conjugates were detected using either anti-Flag or anti-GFP antibody. (C) Immobilized Ulp1(3)(C580S)
was analyzed for its ability to affinity-purify Cdc11 from yeast WCEs. WCE containing GFP-Smt3 (YOK 1857) was prepared under nondenaturing
conditions and incubated with immobilized MBP-Ulp1(3)(C580S), MBP-Ulp1(3)(C580S) lacking the SUMO-binding surface (3(C580S)ΔSBS) or unbound
resin (amylose). After washing and dilution, bound Cdc11 was detected using an anti-Cdc11 antibody (Santa Cruz Biotechnology). (D) WCEs from
logarithmically growing yeast cells expressing GFP-tagged Ulp1(3), Ulp1(3)(C580S) and Ulp1(3)(C580S)ΔSBS (YOK 1839, YOK 1907, YOK 1903) (input)
were prepared under nondenaturing conditions. Extracts were then incubated with SUMO2 immobilized on agarose beads (Boston Biochem).
After washing and elution with sample buffer, bound proteins were detected using an anti-GFP antibody. (E) SUMO2 chains (Boston Biochem)
were incubated with resin-bound MBP-Ulp1(3)(C580S) or unbound resin (amylose). After washing and elution with sample buffer, bound proteins
were detected using an anti-SUMO2 antibody. SUMO2 chains loading control (input). Concentrations of immobilized MBP-Ulp1(3)(C580S) and MBP-
Ulp1(3)(C580S) lacking the SUMO-binding surface (3(C580S)ΔSBS) were confirmed by Coomassie staining of eluted proteins and quantitation on an
Agilent 2100 Bioanalyzer (Agilent Technologies).
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cells could bind immobilized SUMO2, which is highly
conserved to yeast Smt3. In this experiment, yeast cells
expressing CEN-plasmid levels of GFP-tagged Ulp1(3),
Ulp1(3)(C580S) or the Ulp1(3)(C580S)-ΔSBS (see Figure 3)
were grown to log phase prior to preparation of yeast
cell extracts. Individual extracts were then incubated
with SUMO2 immobilized on agarose beads (see Meth-
ods). After washing, bound yeast proteins were eluted,
separated on SDS-PAGE gels and examined by Western
blot analysis with an anti-GFP antibody. This time the
GFP-tagged Ulp1(3)(C580S) could be detected in the
WCEs and bound to the SUMO2 agarose (Figure 6D).
In contrast, neither the WT catalytic domain of Ulp1
(Ulp1(3)) nor Ulp1(3)(C580S)(SBSΔ) was bound to
SUMO2 agarose. Similarly, the Ulp1(3)(C580S) could also
be purified on SUMO1 agarose (data not shown).
We also tested whether immobilized Ulp1(3)(C580S)
could be used to purify SUMO chains. In this experi-
ment, we incubated purified SUMO2 chains with our
immobilized Ulp1(3)(C580S) or the unbound amylose
resin. After washing, bound SUMO2 chains were eluted,
separated on SDS-PAGE gels and examined by Western
blot analysis with an anti-SUMO2 antibody. SUMO2
chains could clearly be detected in the input (Figure 6E,
lane 2) and bound the MBP-Ulp1(3)(C580S) (lane 4), but
not the resin-only control (Figure 6E, lane 3). Both
lower- and higher-molecular-weight adducts of SUMO2
were purified with a preference for higher-molecular-
weight chains (5-mer, 6-mer or 7-mer). These data sug-
gest that Ulp1(3)(C580S) can efficiently bind and enrich
SUMO2 chains in vitro and that the MBP fusion of
Ulp1(3)(C580S) may also be useful for the purification of
sumoylated proteins from mammalian cells.
A SUMO2-binding platform for substrate ubiquitination
STUbLs such as the yeast Slx5/Slx8 heterodimer and the
human RNF4 protein efficiently ubiquitinated proteins
modified with SUMO chains [49,50]. These proteins
interact with their respective sumoylated ubiquitinated
targets through SIMs. STUbL reactions have been
reconstituted in vitro, but the purification of target pro-
teins modified with SUMO chains has been technically
difficult or prohibitively expensive. The ability of Ulp1
(3)(C580S) to interact with SUMO may therefore provide
a simple way to purify a SUMO chain-modified STUbL
target of choice.
To test whether Ulp1(3)(C580S) can serve as a platform
to modify a purified protein with SUMO2 chains, we
incubated the immobilized MBP-Ulp1(3)(C580S) with
SUMO2 chains. Unbound SUMO2 chains were
removed by washing. The MBP-Ulp1(3)(C580S) SUMO2
chain complex was then eluted and added into a
STUbL in vitro ubiquitinated reaction containing
recombinant RNF4 (K A Fryrear and O Kerscher,
unpublished reagents). Proteins in the STUbL-mediated
ubiquitination assay were separated on SDS-PAGE gels
and examined by Western blot analysis with an anti-
SUMO2 antibody (Figure 7A). Consistent with previous
observations, we were able to detect ubiquitinated
SUMO2 chains after the STUbL reaction. This ubiquiti-
nation was dependent on RNF4 and SUMO2 chains.
On the basis of these results, we propose that Ulp1(3)
(C580S) may provide a useful, widely applicable tool for
the study of sumoylated proteins and STUbL targets
(Figure 7B).
Discussion
In this study, we have demonstrated that region 3 of
Ulp1, the catalytic domain, contains critical information
for subcellular targeting to sumoylated substrates,
including the septin Cdc11. To determine how Ulp1 is
targeted to its substrates, we took advantage of a cataly-
tically inactive Ulp1 mutant (C580S) that exhibited par-
tial redistribution from the NE to the septin ring of
dividing yeast cells. We found that the relocalization of
Ulp1 depended on functional Smt3 and sumoylated pro-
teins at the septin ring of dividing cells.
Importantly, using this novel Ulp1 in vivo septin-ring
localization assay, we traced the critical targeting infor-
mation to two features in region 3 of Ulp1, a previously
identified SBS (amino acids 418 to 447) and a SUMO-
contacting residue (D451) that resides near the carboxy
terminus (see structure supplied). D451 of Ulp1 has pre-
viously been shown to contact Smt3 through a salt-
bridge interaction [31,47]. Indeed, in our analysis, we
provide evidence that the salt bridge-disrupting D451N
mutation abolishes the SUMO-dependent targeting of
Ulp1 to septins and prevents the two-hybrid interaction
of the catalytic domain of Ulp1 with Smt3 (Figures 3A,
B and 5).
The sole requirements for the enrichment of full-
length Ulp1 at the septin ring were the catalytically
inactivating C580S mutation in the catalytic domain of
Ulp1 and functional Kap121. This finding has important
implications for the targeting role played by the amino-
terminal karyopherin-binding domains of Ulp1 (dis-
cussed below). Additionally, Smt3 processing appears to
be required for substrate release. The catalytically inac-
tive Ulp1(3)(C580S) mutant is predominantly localized to
the septin ring and nucleus of dividing yeast cells,
whereas the catalytically active WT Ulp1(3) shows
merely diffuse staining throughout the cell (compare
Figure 3B, top). This is not due to differential expression
or stability of either GFP fusion, as similar amounts of
proteins were detected in cell extracts (see Figure 6D).
We propose and show in our biochemical analysis that
the C580S mutant may trap Smt3-modified proteins,
allowing it to be observed in association with cellular
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desumoylation substrates. In support of this assessment,
combining the D451N with the C580S mutation
abolishes all visible bud-neck localization (Figure 3A).
Therefore, we propose that Ulp1(C580S) first targets and
docks Smt3 through the SBS domain and the salt
bridge-forming D451 residue, then traps it in place
because of its inability to cleave after the di-glycine
motif of Smt3. We can assume that a trapped substrate
prevents further catalysis or interactions with other
Smt3 molecules, an assessment that is borne by our
finding that, despite its septin-targeting and SUMO-
binding properties, Ulp1(3)(C580S) interacts only weakly
with Smt3 in a two-hybrid assay (Figure 5 and Addi-
tional file 4). A better understanding of how the sumoy-
lated substrate is trapped by Ulp1(3)(C580S) may have
important implications for the rational design of inhibi-
tors for Ulp1-like SUMO proteases, but may await the
elucidation of the cocrystal structure with a trapped
substrate.
The interaction of budding yeast Ulp1 with Smt3
relies on multiple hydrophobic and salt-bridge interac-
tions between the catalytic domain (region 3) of Ulp1
and the carboxy-terminal extension of Smt3. By making
multiple contacts with Smt3, Ulp1 is particularly well-
Figure 7 MBP-Ulp1(3)(C580S) can serve as a SUMO2 binding platform for SUMO-targeted ubiquitin ligase-mediated substrate
ubiquitination. (A) SUMO2 chains (Boston Biochem) were incubated with resin-bound maltose-binding protein (MBP)-Ulp1(3)(C580S). The
complex of MBP-Ulp1(3)(C580S) with small ubiquitin-like modifier 2 (SUMO2) chains was then eluted and added to an in vitro ubiquitination
reaction with the SUMO-targeted ubiquitin ligase (STUbL) RNF4, an E3 ubiquitin ligase. Proteins in the STUbL reactions were separated by SDS-
PAGE and assessed by Western blot analysis with an anti-SUMO2 antibody. Arrows indicate modified SUMO2 chains. Lane 1: No SUMO chains;
lane 2: no RNF4; lane 3: no Ulp1(3)(C580S); lane 4: all reagents. (B) Proposed model for using MBP-Ulp1(3)(C580S) as a SUMO2-binding platform for
substrate ubiquitination. SUMO2, ubiquitin and RNF4 are indicated by spheres labeled S, spheres labeled Ub and the gray oval labeled RNF4,
respectively.
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suited to interact with a wide variety of sumoylated sub-
strates [22,31]. Other SUMO proteases, Ulp2 and several
SENP proteins (Senp1, Senp2, Senp6 and Senp7), are
believed to interact noncovalently with their sumoylated
substrates through dedicated SIMs [14,22]. On the basis
of our structure-function analysis of region 3, Ulp1
seems to employ a unique mode of interaction with
Smt3 and sumoylated substrates. Ulp1 does not appear
to contain bona fide canonical SIMs, and neither of the
amino-terminal domains of Ulp1 (regions 1 and 2) inter-
act with Smt3 or become enriched at the septin ring
[51]. This assessment is also underscored by the
arrangement of Smt3 and Ulp1 in the cocrystal structure
[31]. The hydrophobic groove of Smt3 that would inter-
act with a SIM-containing protein is turned away from
the domains of Ulp1 that interact with Smt3. Interest-
ingly, this may suggest that Ulp1 can be recruited to
proteins that are covalently or noncovalently modified
with SUMO and SUMO chains.
Our research demonstrates for the first time that non-
covalent interactions between Ulp1 and SUMO are
important not only for SUMO binding but also for the
cytosolic targeting of this SUMO protease to the bud-
neck and potentially to sumoylated septins. Septins are
not the only cytosolic substrates of Ulp1 and are argu-
ably the most prevalent [35,38]; therefore, they may be
readily scored in our septin ring targeting assay (Figures
3A and 3B). We predict that Ulp1 is also targeted to
other cytosolic and septin-bound sumoylated substrate
proteins, such as the karyogamy protein Kar9 [33].
However, because of the low local concentrations in
comparison to sumoylated septins, these proteins may
be hard to detect. We propose, however, that sumoy-
lated proteins that accumulate or aggregate in the cyto-
sol of yeast cells may be readily detectable by Ulp1(3)
(C580S).
As detailed below, Ulp1(3)(C580S) also provides a useful
tool with which to purify these sumoylated proteins
(Figure 6E), and such studies are underway (O Kerscher
and Z C Elmore, unpublished data). Our findings pro-
vide strong evidence that SUMO, at least in the case of
sumoylated proteins at the septin ring, is a required sig-
nal for the cytoplasmic targeting of Ulp1. Our align-
ments of the SBS domain and the juxtaposed salt
bridge-forming D451 residue reveal that this mode of
targeting may also be conserved in other metazoan
Ulp1-like SUMO proteases (Additional file 1).
Though we clearly show herein that Ulp1 becomes
enriched at the septin ring, we do not yet fully under-
stand how Ulp1 arrives at this subcellular localization.
Our findings support the previous observation [27] that
Kap121 plays an important role in promoting Ulp1 tar-
geting to the septin ring. Similar to a previously
described Ulp1 mutant that lacks the Kap60/Kap95
binding domain (region 2) [27], the septin ring localiza-
tion of the full-length Ulp1(C580S) protein described
herein is dependent on functional Kap121. It is unlikely
that the association with Kap121 shuttles Ulp1 to the
septins. Rather, in mitosis, Kap121 becomes associated
with a transport inhibitory nucleoporin, Nup53, and
may thus exclude Ulp1 access to the inner phase of the
NPC [52]. This suggests that, in the absence of Kap121-
binding, a fraction of Ulp1 is free to associate with
sumoylated septins. Our studies confirm that Ulp1 lack-
ing the Kap60/Kap95-binding domain (region 2) is
enriched at the NPC and the septin ring (Figure 3A).
We extend these observations by showing that the abil-
ity to target sumoylated septins resides in the catalytic
domain (region 3) of Ulp1. We found that a Ulp1(3)
(C580S) mutant, but not WT Ulp1(3), is enriched at the
septin ring in the absence of Kap121. These data suggest
that both the Ulp1(3)(C580S) mutant and WT Ulp1(3)
can interact with sumoylated septins, but, unlike the
subtrate-trapping Ulp1(3)(C580S) mutant, the catalytically
active WT Ulp1(3) may be quickly released after desu-
moylation of the target protein, giving it a diffuse
appearance in the cell. How Kap121 helps Ulp1-Δ2 to
be retained at the septin ring in the absence of the
C580S mutation is currently unclear. Kap121 may theo-
retically promote the interaction with a septin ring-loca-
lized protein. However, the localization of Kap121 to
septins has not previously been reported.
One intriguing aspect of our study is the results of our
analysis of the substrate-trapping Ulp1(3)(C580S) con-
struct. Three lines of evidence reveal the avid interaction
of Ulp1(3)(C580S) with SUMO proteins and sumoylated
substrates. First, this Ulp1-derived construct shows a
pronounced interaction with the bud-neck, which is
composed of sumoylated septins in vivo. Second, Ulp1
(3)C580S interacts with Smt3 in a two-hybrid assay,
whereas WT Ulp1(3) does not. Third, the purified
recombinant Ulp1(3)(C580S) protein is a potent affinity-
tag for the purification of Smt3 conjugates and SUMO-
modified proteins. Furthermore, in preliminary BiaCore
analyses, we determined the Kd for the interaction
between Ulp1(3)(C580S) and SUMO1 to be 12.8 nM,
which is about 200 times stronger than the interaction
between a SIM and SUMO, as previously reported by
Hecker and co-workers [53]. A related study involving
the C603S mutant of the human SENP1 protease con-
firms our assessment of the substrate-trapping feature.
Those authors observed relocalization of their SENP1
(C603S) mutant in vivo to PML nuclear bodies and
domains of the HDAC4 protein, suggesting that SUMO-
dependent targeting may be a conserved feature of
Ulp1-like SUMO proteases [54]. The latter may also
provide a useful strategy for the identification of mitoti-
cally important desumoylation substrates. Indeed, two-
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hybrid screens with Ulp1(3)(C580S) in the laboratory have
already identified several novel cytosolic desumoylation
targets (M Donaher and O Kerscher, unpublished data).
We are also exploring the ability of Ulp1(3)(C580S) to act
as a SUMO chain-binding tag that can be used to pro-
mote the interaction of putative STUbL target proteins
with RNF4 and other STUbLs (Figure 7).
How Ulp1 and other SUMO proteases target specific
mitotic substrates for desumoylation remains unknown.
Our analysis of SUMO-dependent Ulp1 targeting to the
septin ring provides important evidence that Ulp1-like
SUMO proteases do not passively await their desumoy-
lation substrates, but rather dynamically localize to
them in a cell-cycle-specific manner. Future experiments
that take advantage of the SUMO-binding properties of
the substrate-trapping Ulp1(3)(C580S) construct may
prove useful for the identification of clinically relevant
targets of conserved Ulp1-like SUMO proteases in yeast
and human cells.
Conclusions
Ulp1 remains one of the most enigmatic SUMO pro-
teases with an essential role in cell-cycle progression.
Our work focuses on the fundamental but unresolved
question of how Ulp1, an NPC-associated SUMO pro-
tease, targets mitotic desumoylation targets in the cyto-
sol. The current study of Ulp1 reveals for the first time
that (1) specific determinants of Ulp1’s catalytic domain
are utilized to target the septins at the bud-neck of
dividing cells, (2) Ulp1 requires SUMO and intact
sumoylation for correct cytosolic targeting, (3) Ulp1,
unlike Ulp2, relies on specific salt bridge-forming resi-
dues for substrate targeting, (4) septin-targeting infor-
mation in the catalytic domain of Ulp1 is independent
of Kap121 and (5) the substrate-targeting domain of
Ulp1 can be modified to identify and purify sumoylated
substrates of Ulp1 in genetic screens and in biochemical
analyses.
Methods
Yeast strains, media and plasmids
The yeast strains and plasmids used in this study are
listed in Table 1. smt3-331 expresses a temperature-sen-
sitive Smt3 protein containing a L26S mutation ([45]
and S Brill, personal communication). smt3R11, 15, 19
expresses a triple-mutant of Smt3 rendered unable to
form SUMO chains through replacement of lysines 11,
15 and 19 with arginines [13]. ulp1ts expresses a tem-
perature-sensitive mutant of Ulp1 that contains three
mutations (I435V, N450S and I504T) in region 3, the
catalytic domain [17]. Yeast media preparation and
manipulation of yeast cells were performed as described
previously [55]. Yeast strains were grown at 30°C unless
otherwise indicated. DNA fragments containing Ulp1
under the control of its endogenous promoter were
amplified from yeast genomic DNA and placed in-frame
with a carboxy-terminal GFP-tag in the CEN/LEU2 plas-
mid pAA3 [56]. Primer pairs used for full-length Ulp1
amplification were OOK2 (ULP1 (-310 to -294)) and
OOK3 (ULP1 (+1, 842 to +1, 863)).
To prepare the truncated and mutated Ulp1-GFP con-
structs listed in Table 1, the QuikChange XL Site-Direc-
ted Mutagenesis Kit (Stratagene/Agilent Technologies,
La Jolla, CA, USA) and the Phusion Site-Directed Muta-
genesis Kit (Finnzymes Oy/Thermo Fisher Scientific,
Vantaa, Finland) were used according to the manufac-
turers’ instructions. Primer sequence information for the
construction of individual mutants and truncations are
available upon request. All constructs were sequenced,
verified and/or confirmed by performing complementa-
tion assays (for example, see Additional file 3). Addi-
tionally, we confirmed that septin rings are intact in
strains expressing plasmid-borne Ulp1(3)C580, WT Ulp1
and Ulp1(3) (see Additional file 5). For two-hybrid con-
structs, ORFs of the indicated genes were PCR-amplified
and recombined into gapped pOAD and pOBD2 vectors
(Yeast Resource Center, Department of Biochemistry
and Department of Genome Sciences, University of
Washington, Seattle, WA, USA).
To overexpress and purify Ulp1 truncations from bac-
teria, the respective Ulp1 fragments were PCR-amplified
and cloned into pMALc-HT (a gift from Sean T Prigge,
Department of Molecular Microbiology and Immunol-
ogy, The Johns Hopkins University School of Public
Health, Baltimore, MD, USA), thereby adding an in-
frame MBP module followed by a TEV protease clea-
vage site and a His6 epitope tag. Ulp1 derivatives were
expressed as MBP fusions in BL21 Star (DE3) cells
(Invitrogen) containing a pRIL plasmid. The YCp-111
Cdc3-CFP/LEU plasmid was a kind gift from Ryuichi
Nishihama of John Pringle’s laboratory (Stanford Uni-
versity School of Medicine, Stanford, CA, USA).
Yeast two-hybrid assays
Gal4-activation domain (AD) fusions of ULP1 and the
indicated ULP1 mutants in pOAD were transformed
into the AH109 reporter strain expressing a Gal4 DNA-
binding domain (BD) fusion of SMT3 in pOBD. Two-
hybrid interactions of serially diluted cells were scored
in duplicate on dropout media lacking adenine.
Pull-down assays, affinity purification and protein extracts
Frozen bacterial cell pellets from 200 ml of isopropyl b-
D-1-thiogalactopyranoside-induced BL21 Star (DE3)
cells were thawed on ice and resuspended in 2 ml of 1
× PBS containing 1 × Halt Protease Inhibitor Cocktail
(catalog no. 78430; Pierce Biotechnology/Thermo Fisher
Scientific, Rockford, IL, USA). Ice-cold cells were
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Table 1 Yeast strains and plasmids
Name Pertinent genotypes or parent strain Plasmids Study/source
MHY500 Mata his3-Δ200 leu2-3, 112 ura3-52 lys2-801trp1-1
gal2
Li and Hochstrasser, 2003
[26]
BY4743 MATa leu2Δ0 met15Δ0 ura3Δ0 Open Biosystems
(Huntsville, AL, USA)
YOK
1611
MHY500 ULP1-GFP/LEU2 This study
YOK
1474
″ ULP1(C580S)-GFP/LEU2 ″
YOK
1490
″ ULP1(Reg1)-GFP/LEU2 ″
YOK
1861
″ UlLP1(Reg2)-GFP/LEU2 ″
YOK
1479
″ ULP1(Δ2)-GFP/LEU2 ″
YOK
2016
″ ULP1(D451N C580S)-GFP/LEU2 ″
YOK
1839
″ ULP1(Reg3)-GFP/LEU2 ″
YOK
1907
″ ULP1(Reg3(C580S))-GFP/LEU2 ″
YOK
1903
″ ULP1((Reg3ΔSBS)-GFP/LEU2 ″
YOK
2203
″ ULP1(SBS)-GFP/LEU2 ″
YOK
1828
″ ULP1((Reg3(ts))-GFP/LEU2 ″
YOK
2157
″ ULP1((Reg3(ts C580S))-GFP/LEU2 ″
YOK
1857
″ SMT3-GFP/LEU2 Panse et al., 2003 [25]
YOK 44 smt3-331 Biggins et al., 2001 [45]
YOK
1995
″ ULP1(C580S)-GFP/LEU2 This study
YOK
847
ubc9-1 Betting and Seufert, 1996
[44]
YOK
2065
″ ULP1(C580S)-GFP/URA3 This study
YOK
2144
″ SMT3-GFP/URA3 ″
GBY1 MATa smt3 R11, 15, 19::TRP1 Bylebyl et al., 2003 [13]
YOK
1910
GBY1 ULP1(C580S)-GFP/LEU2 This study
yDS880 MATa-inc ade2-101 his3-200 leu2-1::GAL-HO-LEU2 lys2-801 RAD53::FLAG-HIS3 siz1::
NAT
siz2::HPH sml1::KAN trp1-63 ura3-52 VII-L::TRP-HO site-LYS2
Schwartz et al., 2007 [46]
YOK
2067
″ ULP1(C580S)-GFP/URA3 This study
YOK
2143
″ SMT3-GFP/URA3 ″
kap121ts kap121::ura3::HIS3 ura3-52 his3Δ200 trp1-1 leu2-3, 112 lys2-801 pRS314-kap121-34 Leslie et al., 2002 [48]
YOK
1487
kap121ts ULP1-GFP/LEU2 This study
YOK
1488
kap121ts ULP1(C580S)-GFP/LEU2 ″
YOK
1944
kap121ts ULP1(Reg3(C580S))-GFP/LEU2 ″
AH109 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, LYS2::GAL1UAS-
GAL1TATA-HIS3, GAL2UAS-GAL2TATA-ADE2, URA3::MEL1UASMEL1TATA-lacZ, MEL1
(cat. no. 630444; Clontech,
Mountain View, CA, USA)
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sonicated using a Branson Sonifier ultrasonic cell dis-
ruptor (Branson Ultrasonics, Danbury, CT, USA), and
extracts were cleared by centrifugation at 15, 000 rpm
for eight minutes at 4°C. Cleared bacterial extracts were
added to 15-ml conical tubes and diluted using 4 ml of
1 × PBS containing the protease inhibitor cocktail.
MBP-tagged proteins (MBP-Ulp1(3), MBP-Ulp1(3)(C580S)
or MBP-Ulp1(3)(C580S)ΔSBS) were bound to 5-ml col-
umns containing 300 μl of amylose resin (New England
Biolabs, Ipswich, MA, USA) and washed extensively
with 1 × PBS. Yeast cell protein extracts containing the
indicated target proteins were passed over the amylose
resin, and proteins bound to MBP-Ulp1(3), MBP-Ulp1
(3)(C580S) or MBP-Ulp1(3)(C580S)ΔSBS were eluted with
100 mM maltose or SDS-PAGE sample buffer. Yeast
cell protein extracts were generated by bead-beating
about 50 nm of yeast cell pellets in 1 × cell lysis buffer
(catalog no. 9803; Cell Signaling Technology, Danvers,
MA, USA) containing 25 mM N-ethylmaleimide.
“Bound” material (Figures 6A and 6B) corresponds to
proteins affinity-purified from approximately 8 nm of
extracted cells. Input (WCE) lysates correspond to 1.25
nm of extracted proteins (about one-sixth the material
loaded onto the column). In SUMO pull-down experi-
ments, recombinant MBP-Ulp1(3)(C580S) or MBP-Ulp1
(3) was incubated with SUMO1 or SUMO2 agarose
(Boston Biochem Inc, Cambridge, MA, USA) in 1 ml of
1 × PBS with protease inhibitors. Proteins bound to the
agarose beads were washed in 1 × PBS and eluted with
1 × SDS-PAGE sample buffer. All protein extracts were
separated on NuPage Novex 4-12% Bis-Tris gradient
gels (NP0321; Invitrogen, Carlsbad, CA, USA) using 3-
morpholinopropane-1-sulfonic acid-SDS running buffer
(NP0001; Invitrogen). Equal loading and concentrations
of recombinant proteins were confirmed by Coomassie
staining and analysis using an Agilent 2100 Bioanalyzer
using a Protein 230 Kit (Agilent Technologies, Santa
Clara, CA, USA). BiaCore measurements were con-
ducted by Affina Biotechnologies, Inc (Stamford, CT,
USA) as a paid service.
Fluorescence microscopy
Unless otherwise noted, cells were grown in rich media,
arrested in G2/M using nocodazole (15 μg/ml/3 hours/
30°C), washed in 2% dextrose and harvested by centrifu-
gation. Images of live cells were collected using a Zeiss
Axioskop microscope (Carl Zeiss USA, Thornwood, NY,
USA) fitted with a QImaging Retiga™ SRV charge-
coupled device digital camera (QImaging, Surrey, BC,
Canada), i-Vision-Mac software (BioVision Technolo-
gies, Exton, PA, USA) and a Uniblitz electro-program-
mable shutter assembly system (Vincent Associates/
UNIBLITZ, Rochester, NY, USA). Pertinent filter sets
for the above applications include CZ909 (GFP), XF114-
2 (CFP) and XF104-2 (YFP) (Chroma Technology
Group, Bellows Falls, VT, USA). Images were normal-
ized using i-Vision-Mac software and pseudocolored
and adjusted using Adobe Photoshop software (Adobe
Systems Inc, San Jose, CA, USA).
In vitro ubiquitination reactions, recombinant proteins
and antibodies
Enzymes and substrates used in our in vitro ubiquitina-
tion assays were quantified using a Protein 230 Kit on
the Agilent 2100 Bioanalyzer (Agilent Technologies)
according to the manufacturer’s instructions. We used
10 × ubiquitination buffer, E1 enzyme (Uba1), ATP and
20 × ubiquitin provided in a commercial ubiquitin acti-
vating kit (BML-UW0400-0001; Enzo Life Sciences Inc,
Farmingdale, NY, USA). Ubiquitination buffer, isopente-
nyl diphosphate (100 U/ml), dithiothreitol (DTT) (50
μM), E1 (Uba1), E2 (Ubc4) and E3 enzymes (RNF4)
Table 1 Yeast strains and plasmids (Continued)
YOK
2212
AH109 ULP1 (Reg3(D451N C580S))-
pOAD/LEU2 + SMT3-pOBD/
TRP1
This study
YOK
2173
″ ULP1 (Reg3(C580S))-pOAD/LEU2
+ SMT3-pOBD/TRP1
″
YOK
2175
″ ULP1 (Reg3(D451N))-pOAD/LEU2
+ SMT3-pOBD/TRP1
″
YOK
2177
″ ULP1 (Reg3(ts))-pOAD/LEU2 +
SMT3-pOBD/TRP1
″
YOK
2181
″ ULP1 (Reg3(ts C580S))-pOAD/
LEU2 + SMT3-pOBD/TRP1
″
YOK
2183
″ SMT3-pOAD/LEU2 + SLX5
pOBD/TRP1
″
YOK
2185
″ vector-pOAD/LEU2 + vector
pOBD/TRP1
″
YOK
428
ulp1::KAN (segregant of heterozygous diploid ULP1/ulp1::KAN in BY4743 - (Open
Biosystems, Huntsville, AL, USA (cat. no. YSC1021-671376)
ulp1ts/TRP/NAT
GPD-FLAG-SMT3gg/pRS425
″
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were combined with purified SUMO2 chains (ULC-210;
Boston Biochem) and ubiquitin. Reactions totaled 27 μl
and were incubated at 30°C for three hours. Reactions
were stopped by adding an equal volume of SUMEB
with Tris (SUTEB) sample buffer (0.01% bromophenol
blue, 10 mM ethylenediaminetetraacetic acid, 1% SDS,
50 mM Tris, pH 6.8, 8 M urea) containing DTT (5 μl of
1 M DTT mixed with 1 ml SUTEB sample buffer). Pro-
tein products were boiled in a 65°C heat block for ten
minutes and examined by Western blot analysis with
anti-human SUMO2 antibody, anti-human SUMO2
(BML-PW0510-0025; Enzo Life Sciences Inc), anti-GFP
(JL-8 632380; Clontech, Mountain View, CA), ANTI-
FLAG M2 (F3165; Sigma-Aldrich, St Louis, MO, USA),
anti-phosphoglycerate kinase (22C5D8; Invitrogen), anti-
Cdc11 (y415) (sc-7170; Santa Cruz Biotechnology, Santa
Cruz, CA, USA).
Additional material
Additional file 1: Supplementary Figure S1. (A) Identification of
important features required for Ulp1 targeting and small ubiquitin-like
modifier (SUMO) binding. The yeast Ulp1 catalytic domain was BLASTed
against all nonredundant protein sequences in the National Center for
Biotechnology Information database using psi-blast http://blast.ncbi.nlm.
nih.gov/Blast.cgi. After seven iterations, the top 100 query sequences
(only 11 are shown) were aligned, which included a variety of animal,
plant and fungal species. Residues that constitute the SUMO-binding
surface (SBS) are shown in red. Also indicated are the salt bridge forming
D451 and one of the residues mutated in the ulp1ts allele, N450.
Conservation: Conservation of amino acid properties. Quality: Alignment
quality based on Blosum 62 scores. High values suggest no or
conservative mutations. Consensus: Percentage identity. All values were
calculated using Jalview http://www.jalview.org/[59]. (B) Consensus SBS
based on the alignment of 250 sequences from 81 species. The height of
the letters corresponds to the frequency of the amino acid in the
alignment. The width is based on the proportion of sequences that
contain a character (many gaps lead to narrow letters). Also indicated are
the salt bridge forming D451 and one of the residues mutated in the
ulp1ts allele, N450 (WebLogo 3; http://weblogo.threeplusone.com/) [60].
Additional file 2: Supplementary Figure S2. Three dimensional
representation of the cocrystal structure of the catalytic domain of Ulp1
(Ulp1(3), magenta) with yeast small ubiquitin-like modifier (SUMO) (Smt3,
blue). N450, D451 and C580 are indicated in yellow and labeled with the
appropriate amino acids. Also shown is the SUMO-binding surface (SBS).
Additional file 3: Supplementary Figure S3. Complementation analysis
of Ulp1-GFP fusion constructs. ULP1-GFP and ULP1(3)-GFP fusion
constructs complement the growth phenotype of a ulp1 deletion strain.
A ulp1 shuffle strain (ulp1::HIS3, ULP1/URA3) was transformed with one of
the following low-copy plasmids: ULP1-GFP, ULP1-region 1-GFP, ULP1-
region 2-GFP, ULP1(3)-GFP, ULP1(3)C580S-GFP or the empty vector.
Transformants were streaked onto yeast extract peptone dextrose
medium and then medium containing 5-fluoroorotic acid to select for
loss of the ULP1/URA3 plasmid. Note that, as expected, only the ULP1-
GFP and ULP1(3)-GFP fusion constructs complement the growth
phenotype of the ulp1 deletion strain.
Additional file 4: Supplementary Figure S4. Two-hybrid analysis of
Ulp1(3)C580S and Ulp1(3)C580A (isolates 1A and 3A) with small
ubiquitin-like modifier (SUMO)/Smt3-BD. The presence of both Smt3
(pOBD2/TRP1) and Ulp1 constructs (pOAD/LEU2) was confirmed by
growth on growth media lacking tryptophan and leucine (right plate).
The interaction between the indicated Ulp1 constructs and Smt3 is
shown as triplicate patches of cells on media lacking adenine (left plate).
Additional file 5: Supplementary Figure S5. Analysis of septin rings in
yeast strains expressing various Ulp1 constructs. Strains expressing Ulp1
(3)(C580S), full-length Ulp1(WT) or Ulp1(3) were fixed and attached to glass
slides. The septin Cdc11 was detected using an anti-Cdc11 antibody.
Bud-neck localized Cdc11, 4’, 6-diamidino-2-phenylindole-stained nuclear
DNA and the overlaid images with pseudocolored red septins and blue
DNA are shown. Note that all strains show bud-neck, localized, well-
defined septin rings.
Abbreviations
AD: Gal4-activation domain; BD: Gal4-binding domain; GFP: green
fluorescent protein; Kd: dissociation constant; MBP: maltose-binding protein;
NPC: nuclear pore complex; ORF: open reading frame; PBS: phosphate-
buffered saline; SBS: SUMO binding surface; STUbL: SUMO-targeted ubiquitin
ligase; SUMO: small ubiquitin-like modifier; UD: ubiquitin-like protease
domain; Ulp1: ubiquitin-like protease 1; YFP: yellow fluorescent protein.
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